Publication | Open Access

Dose Conversion and Titration with a Novel, Once-Daily, OROS® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

Pain TherapyInterventional Pain MedicineHealth SciencesPain MedicineDose ConversionPharmacologyCancer PainPharmacotherapyPain ManagementOros® Osmotic TechnologyExtended-release Hydromorphone FormulationMedicinePain Research